Joni K. Doherty

2.0k total citations
62 papers, 1.4k citations indexed

About

Joni K. Doherty is a scholar working on Neurology, Oncology and Epidemiology. According to data from OpenAlex, Joni K. Doherty has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Neurology, 24 papers in Oncology and 16 papers in Epidemiology. Recurrent topics in Joni K. Doherty's work include Ear and Head Tumors (18 papers), Neurofibromatosis and Schwannoma Cases (18 papers) and Meningioma and schwannoma management (16 papers). Joni K. Doherty is often cited by papers focused on Ear and Head Tumors (18 papers), Neurofibromatosis and Schwannoma Cases (18 papers) and Meningioma and schwannoma management (16 papers). Joni K. Doherty collaborates with scholars based in United States, France and Australia. Joni K. Doherty's co-authors include Fred H. Linthicum, Gail M. Clinton, William H. Slattery, Laurel M. Fisher, Allen F. Ryan, Karen I. Berliner, Elizabeth E. Ramsey, Rebecca Holmes, Ying-Ju Lin and Edward J. Keenan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and Oncogene.

In The Last Decade

Joni K. Doherty

57 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joni K. Doherty United States 21 472 369 358 303 293 62 1.4k
William W. M. Lo United States 22 448 0.9× 228 0.6× 452 1.3× 365 1.2× 147 0.5× 43 1.4k
Chris Halpin United States 18 153 0.3× 354 1.0× 825 2.3× 159 0.5× 313 1.1× 36 1.5k
Tetsuya Tono Japan 21 244 0.5× 301 0.8× 180 0.5× 718 2.4× 248 0.8× 120 1.3k
Masaaki Kitahara Japan 23 506 1.1× 541 1.5× 99 0.3× 199 0.7× 741 2.5× 134 1.8k
Flemming S. Vassbotn Norway 17 169 0.4× 90 0.2× 335 0.9× 171 0.6× 139 0.5× 30 1.1k
Shin‐Ichi Haginomori Japan 18 235 0.5× 123 0.3× 189 0.5× 252 0.8× 133 0.5× 75 911
Wong‐Kein Low Singapore 18 348 0.7× 219 0.6× 74 0.2× 342 1.1× 84 0.3× 56 902
Meredith E. Adams United States 18 67 0.1× 222 0.6× 111 0.3× 260 0.9× 266 0.9× 58 951
Hans Ramsay Finland 17 149 0.3× 101 0.3× 116 0.3× 518 1.7× 133 0.5× 56 801
Valeria Cuccarini Italy 20 139 0.3× 135 0.4× 146 0.4× 42 0.1× 208 0.7× 46 909

Countries citing papers authored by Joni K. Doherty

Since Specialization
Citations

This map shows the geographic impact of Joni K. Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joni K. Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joni K. Doherty more than expected).

Fields of papers citing papers by Joni K. Doherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joni K. Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joni K. Doherty. The network helps show where Joni K. Doherty may publish in the future.

Co-authorship network of co-authors of Joni K. Doherty

This figure shows the co-authorship network connecting the top 25 collaborators of Joni K. Doherty. A scholar is included among the top collaborators of Joni K. Doherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joni K. Doherty. Joni K. Doherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nghiemphu, Phioanh L., Jérémie Vitte, Eva Dombi, et al.. (2024). Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma. Journal of Neuro-Oncology. 167(2). 339–348. 2 indexed citations
3.
Pan, Dorothy W., et al.. (2022). Idiopathic Intracranial Hypertension. Otolaryngologic Clinics of North America. 55(3). 579–594. 5 indexed citations
4.
Doherty, Joni K., et al.. (2021). An Exploration of Online Support Community Participation Among Patients With Vestibular Disorders. The Laryngoscope. 132(9). 1835–1842. 9 indexed citations
5.
Ishiyama, Akira, Joni K. Doherty, Gail Ishiyama, et al.. (2016). Post Hybrid Cochlear Implant Hearing Loss and Endolymphatic Hydrops. Otology & Neurotology. 37(10). 1516–1521. 48 indexed citations
6.
Brown, Carrie M., et al.. (2011). ErbB Expression, Activation, and Inhibition With Lapatinib and Tyrphostin (AG825) in Human Vestibular Schwannomas. Otology & Neurotology. 32(5). 841–847. 23 indexed citations
7.
Baik, Fred M., Linda Nguyen, Joni K. Doherty, et al.. (2011). Comparative Case Series of Exostoses and Osteomas of the Internal Auditory Canal. Annals of Otology Rhinology & Laryngology. 120(4). 255–260. 17 indexed citations
8.
Altuna, Xabier, Jay Patrick Lopez, Michael Yu, et al.. (2010). Potential Role of Imatinib Mesylate (Gleevec, STI-571) in the Treatment of Vestibular Schwannoma. Otology & Neurotology. 32(1). 163–170. 18 indexed citations
9.
Blair, Katherine J., Alan Kiang, Jessica Wang‐Rodriguez, et al.. (2010). EGF and bFGF Promote Invasion That Is Modulated by PI3/Akt Kinase and Erk in Vestibular Schwannoma. Otology & Neurotology. 32(2). 308–314. 34 indexed citations
10.
Alexander, Thomas H., et al.. (2010). Laterality of Exostosis in Surfers Due to Evaporative Cooling Effect. Otology & Neurotology. 31(2). 345–351. 24 indexed citations
11.
Fisher, Laurel M., Joni K. Doherty, Michael H. Lev, & William H. Slattery. (2009). Concordance of Bilateral Vestibular Schwannoma Growth and Hearing Changes in Neurofibromatosis 2. Otology & Neurotology. 30(6). 835–841. 55 indexed citations
12.
Alexander, Thomas H., et al.. (2008). Vestibular Schwannoma Quantitative Polymerase Chain Reaction Expression of Estrogen and Progesterone Receptors. The Laryngoscope. 118(8). 1458–1463. 20 indexed citations
13.
Doherty, Joni K., Weg M. Ongkeko, Brianna K. Crawley, Ali Andalibi, & Allen F. Ryan. (2008). ErbB and Nrg. Otology & Neurotology. 29(1). 50–57. 48 indexed citations
14.
Brackmann, Derald E. & Joni K. Doherty. (2007). CPA Melanoma. Otology & Neurotology. 28(4). 529–537. 21 indexed citations
15.
Doherty, Joni K. & Rick A. Friedman. (2006). Controversies in building a management algorithm for vestibular schwannomas. Current Opinion in Otolaryngology & Head & Neck Surgery. 14(5). 305–313. 23 indexed citations
16.
Doherty, Joni K. & Dennis R. Maceri. (2005). Ossicular Discontinuity and Exostoses in Proteus Syndrome: A Case Report. Annals of Otology Rhinology & Laryngology. 114(3). 242–246. 1 indexed citations
17.
Doherty, Joni K. & Fred H. Linthicum. (2004). Cochlear Endosteal Erosion with Focal Osteomyelitis Induced by Cochlear Implantation. Otology & Neurotology. 25(6). 1029–1030. 12 indexed citations
19.
Doherty, Joni K., et al.. (2001). Pathology Quiz Case. Archives of Otolaryngology - Head and Neck Surgery. 127(9). 1133–1133. 2 indexed citations
20.
Doherty, Joni K., Chris T. Bond, Armando Jardim, John P. Adelman, & Gail M. Clinton. (1999). The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor. Proceedings of the National Academy of Sciences. 96(19). 10869–10874. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026